StocksTelegraph
S&P 500—NASDAQ—DOW—RUSSELL—
NASDAQ · MLEC·Healthcare

Moolec Science S.A. Stock Analysis & AI Score

Moolec Science S.A. (MLEC) has an ST Score of 43.0 (C), driven by its Forecast (A) and held back by its Momentum (D+). Analysts rate it Buy with a $45.00 price target (+669.2% upside).

Market Closed
$5.85
Prev Close
—
Market Cap
—
Day Range
—
52W Range
—
P/E
—
EPS (TTM)
—
Volume
—
Avg —
Beta
—
43
ST Score
43.0/100C

Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.

As of
AI Daily Briefing
Analysis by AI
Price History
—
Technical Indicators
FMP
Earnings Surprises
Analyst Forecast
Revenue Mix

Company Information

Employees—
CEO—
SectorHealthcare
IndustryBiotechnology
IPO Date—
Website—
Country—
ExchangeNASDAQ

SEC Filings

Annual Report (10-K)

Filing DateAcceptedLink
Loading…

Quarterly Report (10-Q)

Filing DateAcceptedLink
Loading…
Analyst Price Target
ESG Score
Latest News

ST Score

MLEC
43.0out of 100
Grade C

Moolec Science S.A. (MLEC) has an ST Score of 43.0 (C), driven by its Forecast (A) and held back by its Momentum (D+). Analysts rate it Buy with a $45.00 price target (+669.2% upside).

Strongest
ForecastA
Weakest
MomentumD+
All factor grades
  • ForecastA
  • ProfitabilityB+
  • ValuationC
  • GrowthC
  • Financial StrengthC-
  • MomentumD+
  • Piotroski1/9
Score methodology
Press Releases

Contact

MLEC stock: frequently asked questions

What is MLEC's ST Score?

Moolec Science S.A. (MLEC) has an ST Score of 43.0 (C), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.

Is MLEC a buy, hold, or sell?

Analysts rate MLEC a Buy, with a price target of $45.00 (+669.2% vs the current price). Our ST Score grades it C (43.0/100). The ST Score is a data-driven signal, not a recommendation.

What are MLEC's factor grades?

Valuation C, Profitability B+, Financial Strength C-, Momentum D+, Growth C, Forecast A.

What is MLEC's valuation grade?

Moolec Science S.A. (MLEC) earns a valuation grade of C, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.

What is MLEC's growth grade?

Moolec Science S.A. (MLEC) earns a growth grade of C, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.

What is MLEC's profitability grade?

Moolec Science S.A. (MLEC) earns a profitability grade of B+, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.

What is MLEC's financial strength grade?

Moolec Science S.A. (MLEC) earns a financial strength grade of C-, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.

What is the analyst price target for MLEC?

The average analyst price target for Moolec Science S.A. (MLEC) is $45.00 from 1 analysts, which is +669.2% versus the recent price of $5.85.

What is MLEC's Piotroski score?

Moolec Science S.A. (MLEC) has a Piotroski F-Score of 1 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.